This SPA provides authority to establish hospital reimbursement, separate from the Diagnosis Related Group (DRG) payment, for Spinraza and drugs for which the State has entered CMS approved outcomes-based contract arrangements with drug manufacturers for drugs provided to Medicaid beneficiaries.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media